慢性脑脊髓静脉功能不全与梅尼埃病:介入与药物治疗对比
这项前瞻性病例对照研究纳入412例明确梅尼埃病患者和102例健康对照,发现慢性脑脊髓静脉功能不全在患者中占80.1%、对照中占11.8%(P<.001)。在伴该功能不全的梅尼埃病患者中,双侧颈静脉/奇静脉经皮腔内血管成形术组在头晕残障量表、耳闷胀感和纯音平均听阈上优于药物治疗组。
要点
- 梅尼埃病患者中慢性脑脊髓静脉功能不全的发生率显著高于健康对照。
- 血管介入组头晕残障评分和纯音平均听阈优于药物治疗组。
- 耳鸣残障量表评分在介入与药物治疗组间无显著差异。
核心结论
- 研究结果证实血管性疾病与梅尼埃病之间存在密切关系。
- 血管介入治疗对梅尼埃病症状的积极反应提示其可能是理解和治疗该复杂疾病的有前景方向。
研究设计与样本
- 所有患者均接受听前庭和血管检查。
- 伴慢性脑脊髓静脉功能不全的梅尼埃病患者分为两组:接受双侧颈静脉/奇静脉经皮腔内血管成形术(PTA)组和药物治疗组。
主要发现
- 慢性脑脊髓静脉功能不全在330/412(80.1%)梅尼埃病患者和12/102(11.8%)健康个体中诊断(P < .001)。
- 在慢性脑脊髓静脉功能不全亚组中,PTA组与药物治疗组的头晕残障量表评分分别为31 ± 8.6和48.1 ± 14.4(P < .001)。
- 耳鸣残障量表评分在PTA组和药物治疗组分别为50.8 ± 16.58和49.6 ± 17.5(P = .23),无显著差异。
- 耳闷胀感的主观评估在PTA组显著更好(P = .003)。
- 纯音平均听阈在PTA组为49.8 ± 16.5 dB,药物治疗组为55.8 ± 13 dB(P = .035),组间有显著差异。
临床怎么用
- 对于梅尼埃病患者,可评估是否存在慢性脑脊髓静脉功能不全。
- 在伴慢性脑脊髓静脉功能不全的梅尼埃病患者中,血管介入治疗可能改善头晕、耳闷胀感和听力,但需结合耳鸣情况综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To evaluate the incidence of chronic cerebrospinal venous insufficiency in Menière's disease patients and the effect of bilateral percutaneous transluminal angioplasty of the jugular/azygos veins compared to medical therapy. STUDY DESIGN: Prospective case-control study. METHODS: Five hundred fourteen subjects were included in the study, 412 affected by definite Menière's disease, and 102 healthy controls. All patients underwent audiovestibular and vascular examination. Patients with Menière's disease and concomitant cerebrospinal venous insufficiency were divided in two subgroups: patients who underwent vascular intervention with bilateral percutaneous transluminal angioplasty (PTA) of the jugular/azygos veins and patients treated with medical therapy. RESULTS: Chronic cerebrospinal venous insufficiency was diagnosed in 330/412 (80.1%) Menière's disease patients and in 12/102 healthy individuals (11.8%) (P < .001). In the two chronic cerebrospinal venous insufficiency subgroups, a significant difference in Dizziness Handicap Inventory scores was found between patients in the PTA group compared to patients treated with medical therapy (31 ± 8.6 vs. 48.1 ± 14.4; P < .001); no significant differences were found for the Tinnitus Handicap Inventory scores (50.8 ± 16.58 vs. 49.6 ± 17.5; P = .23). Subjective evaluation of aural fullness was significantly better in patients in the PTA group (P = .003) as well as pure-tone average, which was significantly different between groups (49.8 ± 16.5 dB in the PTA group vs. 55.8 ± 13 in the medical therapy group; P = .035). CONCLUSIONS: The results of the present study confirm the close relationship between vascular disorders and Menière's disease. The encouraging responses to vascular interventional therapy on Meniére's disease symptoms suggest that this may be a promising path for interpretation and treatment of this complex disease. LEVEL OF EVIDENCE: 2b Laryngoscope, 130: 2040-2046, 2020.
引用
- Attanasio G, Califano L, Bruno A, et al. Chronic cerebrospinal venous insufficiency and menière's disease: Interventional versus medical therapy. Laryngoscope. 2019. PMID: 31710712. doi:10.1002/lary.28389
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。